Thomas C. Frost

Thomas C. Frost

Auto-generated profile, based on publicly available information

Thomas C. Frost

Program in Virology, The Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
PLPatrick C. Lee
Patrick C. Lee
SKSusan Klaeger
Susan Klaeger
PLPhuong M. Le
Phuong M. Le
KKKeegan Korthauer
Keegan Korthauer
JCJingwei Cheng
Jingwei Cheng
DKDerin B. Keskin
Derin B. Keskin
Cancers avoid immune surveillance through an array of mechanisms, including perturbation of HLA class I antigen presentation. Merkel cell carcinoma (MCC) is an aggressive, HLA-I–low, neuroendocrine carcinoma of the skin often caused by the Merkel cell polyomavirus (MCPyV). Through the characterization of 11 newly generated MCC patient-derived cell lines, we identified transcriptional suppression of several class I antigen presentation genes. To systematically identify regulators of HLA-I loss in MCC, we performed parallel, genome-scale, gain- and loss-of-function screens in a patient-derived MCPyV-positive cell line and identified MYCL and the non-canonical Polycomb repressive complex 1.1 (PRC1.1) as HLA-I repressors. We observed physical interaction of MYCL with the MCPyV small T viral antigen, supporting a mechanism of virally mediated HLA-I suppression. We further identify the PRC1.1 component USP7 as a pharmacologic target to restore HLA-I expression in MCC.

1 March 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
TFThomas C. Frost
Thomas C. Frost
AGAshley K. Gartin
Ashley K. Gartin
MLMofei Liu
Mofei Liu
JCJingwei Cheng
Jingwei Cheng
HDHarita Dharaneeswaran
Harita Dharaneeswaran
JDJames DeCaprio
James DeCaprio
BACKGROUND. Merkel cell carcinoma (MCC) is an aggressive neuroendocrine (NE) skin cancer caused by severe UV-induced mutations or expression of Merkel cell polyomavirus (MCPyV) large and small T antigens (LT and ST). Despite deep genetic differences between MCPyV-positive and -negative subtypes, current clinical diagnostic markers are indistinguishable between subtypes and the expression profile of MCC tumors is unexplored. METHODS. Here we leveraged bulk and single-cell RNA sequencing of patient-derived tumor biopsies and cell lines to explore the underlying transcriptional diversity of MCC. RESULTS. Strikingly, MCC samples could be separated into transcriptional subtypes that were independent of MCPyV status. Instead, we observed an inverse correlation between a NE gene signature and the Hippo pathway transcription factors Yes1-associated transcriptional regulator (YAP1) and WW domain containing transcriptional regulator (WWTR1). This inverse correlation was present at the transcript and protein levels in the tumor biopsies as well as in established and patient-derived cell lines. Mechanistically, expression of YAP1 or WWTR1 in a MCPyV-positive MCC cell line induced cell-cycle arrest at least in part through TEAD-dependent transcriptional repression of MCPyV LT. CONCLUSION. These findings describe previously unrecognized heterogeneity in NE gene expression within MCC and support the model that YAP1/WWTR1 silencing is essential for the development of MCPyV-positive MCC. FUNDING. US Public Health Service grants R35CA232128, P01CA203655, and P30CA06516.

1 October 2018 in Current Opinion in Virology
Verified
Journal Article
Closed access
TFThomas C Frost
Thomas C Frost
BGBenjamin Gewurz`
Benjamin Gewurz`

21 March 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
AGAshley K. Gartin
Ashley K. Gartin
TFThomas C. Frost
Thomas C. Frost
CCCamille H. Cushman
Camille H. Cushman
BLBrittaney A. Leeper
Brittaney A. Leeper
PGPrafulla C. Gokhale
Prafulla C. Gokhale
JDJames DeCaprio
James DeCaprio

8 August 2022 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
MAMona M. Ahmed
Mona M. Ahmed
HRHembly G. Rivas
Hembly G. Rivas
TFThomas C. Frost
Thomas C. Frost
JDJames DeCaprio
James DeCaprio